Finepoint Capital LP Diversified Active

CIK: 0001608126 · Show all filings

Period: Q3 2023 (← Previous) (Next →)

Filing Date: Nov 13, 2023

Total Value ($000): $200,795 (100.0% shares, 0.0% debt)

Holdings (30)

MLTX MOONLAKE IMMUNOTHERAPEUTICS 9.4%

Value ($000) $18,891 Shares 331,416 Est. Cost $29.42 Unrealized +87.6%

FOLD AMICUS THERAPEUTICS INC 9.0%

Value ($000) $18,107 Shares 1,489,025 Est. Cost $8.83 Unrealized +46.2%

SRPT SAREPTA THERAPEUTICS INC 8.8%

Value ($000) $17,620 Shares 145,357 Est. Cost $115.73 Unrealized -2.3%

PRTA PROTHENA CORP PLC 8.4%

Value ($000) $16,854 Shares 349,300 Est. Cost $33.98 Unrealized +74.8%

GLPG GALAPAGOS NV 7.9%

Value ($000) $15,847 Shares 458,659 Est. Cost $47.20 Unrealized —

ASND ASCENDIS PHARMA A/S 7.6%

Value ($000) $15,336 Shares 163,772 Est. Cost $89.38 Unrealized —

— SPRINGWORKS THERAPEUTICS INC 6.4%

Value ($000) $12,876 Shares 556,928 Est. Cost $13.68 Unrealized —

CYTK CYTOKINETICS INC 6.3%

Value ($000) $12,718 Shares 431,693 Est. Cost $39.39 Unrealized -15.4%

— CEREVEL THERAPEUTICS HLDNG I 6.1%

Value ($000) $12,298 Shares 563,345 Est. Cost $27.31 Unrealized —

RVMD REVOLUTION MEDICINES INC 5.9%

Value ($000) $11,819 Shares 427,000 Est. Cost $29.66 Unrealized 0.0%

ACAD ACADIA PHARMACEUTICALS INC 5.8%

Value ($000) $11,599 Shares 556,553 Est. Cost $17.65 Unrealized +53.8%

ARVN ARVINAS INC 4.9%

Value ($000) $9,912 Shares 504,700 Est. Cost $42.02 Unrealized -41.6%

TVTX TRAVERE THERAPEUTICS INC 4.0%

Value ($000) $8,009 Shares 895,821 Est. Cost $23.75 Unrealized -40.6%

— MORPHIC HOLDING INC 3.7%

Value ($000) $7,454 Shares 325,356 Est. Cost $53.33 Unrealized —

RLAY RELAY THERAPEUTICS INC 3.6%

Value ($000) $7,324 Shares 870,870 Est. Cost $17.36 Unrealized -38.1%

SLDB SOLID BIOSCIENCES INC 1.2%

Value ($000) $2,422 Shares 961,251 Est. Cost $5.95 Unrealized -34.8%

— CALIDI BIOTHERAPEUTICS INC 0.2%

Value ($000) $416 Shares 125,000 Est. Cost $3.33 Unrealized —

— ARES ACQUISITION CORP 0.2%

Value ($000) $334 Shares 504,706 Est. Cost $0.85 Unrealized —

— BRIDGETOWN HOLDINGS LTD 0.2%

Value ($000) $304 Shares 895,000 Est. Cost $1.24 Unrealized —

— CHURCHILL CAPITAL CORP VII 0.1%

Value ($000) $169 Shares 548,000 Est. Cost $0.92 Unrealized —

CLDWW CALIDI BIOTHERAPEUTICS INC 0.1%

Value ($000) $144 Shares 655,200 Est. Cost $0.50 Unrealized —

CDAWF COMPASS DIGITAL ACQUISITION CORP 0.1%

Value ($000) $101 Shares 459,906 Est. Cost $0.76 Unrealized —

— CHURCHILL CAPITAL CORP VI 0.0%

Value ($000) $86 Shares 540,000 Est. Cost $1.20 Unrealized —

— ROSS ACQUISITION CORP II 0.0%

Value ($000) $49 Shares 439,666 Est. Cost $0.89 Unrealized —

CNDAW CONCORD ACQUISITION CORP II 0.0%

Value ($000) $43 Shares 408,333 Est. Cost $0.95 Unrealized —

IVCPW SWIFTMERGE ACQUISITION CORP 0.0%

Value ($000) $35 Shares 490,000 Est. Cost $0.21 Unrealized —

LSBWF YS BIOPHARMA CO LTD 0.0%

Value ($000) $17 Shares 489,999 Est. Cost $0.16 Unrealized —

— MARBLEGATE ACQUISITION CORP 0.0%

Value ($000) $14 Shares 735,000 Est. Cost $0.50 Unrealized —

— HOME PLATE ACQUISITION CORP 0.0%

Value ($000) $0 Shares 690,000 Est. Cost $0.60 Unrealized —

— CHURCHILL CAPITAL CORP V 0.0%

Value ($000) $0 Shares 612,000 Est. Cost $1.30 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
MLTX	MOONLAKE IMMUNOTHERAPEUTICS	331,416	$18,891	9.4%	$29.42	+87.6%	CLASS A ORD	61559X104
FOLD	AMICUS THERAPEUTICS INC	1,489,025	$18,107	9.0%	$8.83	+46.2%	COM	03152W109
SRPT	SAREPTA THERAPEUTICS INC	145,357	$17,620	8.8%	$115.73	-2.3%	COM	803607100
PRTA	PROTHENA CORP PLC	349,300	$16,854	8.4%	$33.98	+74.8%	SHS	G72800108
GLPG	GALAPAGOS NV	458,659	$15,847	7.9%	$47.20	—	SPON ADR	36315X101
ASND	ASCENDIS PHARMA A/S	163,772	$15,336	7.6%	$89.38	—	SPONSORED ADR	04351P101
—	SPRINGWORKS THERAPEUTICS INC	556,928	$12,876	6.4%	$13.68	—	COM	85205L107
CYTK	CYTOKINETICS INC	431,693	$12,718	6.3%	$39.39	-15.4%	COM NEW	23282W605
—	CEREVEL THERAPEUTICS HLDNG I	563,345	$12,298	6.1%	$27.31	—	COM	15678U128
RVMD	REVOLUTION MEDICINES INC	427,000	$11,819	5.9%	$29.66	0.0%	COM	76155X100
ACAD	ACADIA PHARMACEUTICALS INC	556,553	$11,599	5.8%	$17.65	+53.8%	COM	004225108
ARVN	ARVINAS INC	504,700	$9,912	4.9%	$42.02	-41.6%	COM	04335A105
TVTX	TRAVERE THERAPEUTICS INC	895,821	$8,009	4.0%	$23.75	-40.6%	COM	89422G107
—	MORPHIC HOLDING INC	325,356	$7,454	3.7%	$53.33	—	COM	61775R105
RLAY	RELAY THERAPEUTICS INC	870,870	$7,324	3.6%	$17.36	-38.1%	COM	75943R102
SLDB	SOLID BIOSCIENCES INC	961,251	$2,422	1.2%	$5.95	-34.8%	COM NEW	83422E204
—	CALIDI BIOTHERAPEUTICS INC	125,000	$416	0.2%	$3.33	—	COM NEW	320703101
—	ARES ACQUISITION CORP	504,706	$334	0.2%	$0.85	—	*W EXP 02/02/202	G33032122
—	BRIDGETOWN HOLDINGS LTD	895,000	$304	0.2%	$1.24	—	*W EXP 09/30/202	G1355U121
—	CHURCHILL CAPITAL CORP VII	548,000	$169	0.1%	$0.92	—	*W EXP 02/29/202	17144M110
CLDWW	CALIDI BIOTHERAPEUTICS INC	655,200	$144	0.1%	$0.50	—	*W EXP 03/14/202	320703119
CDAWF	COMPASS DIGITAL ACQUISITION CORP	459,906	$101	0.1%	$0.76	—	*W EXP 09/29/202	G2476C123
—	CHURCHILL CAPITAL CORP VI	540,000	$86	0.0%	$1.20	—	*W EXP 02/17/202	17143W119
—	ROSS ACQUISITION CORP II	439,666	$49	0.0%	$0.89	—	*W EXP 02/01/202	G7641C114
CNDAW	CONCORD ACQUISITION CORP II	408,333	$43	0.0%	$0.95	—	*W EXP 99/99/999	20607U116
IVCPW	SWIFTMERGE ACQUISITION CORP	490,000	$35	0.0%	$0.21	—	*W EXP 12/13/202	G63836111
LSBWF	YS BIOPHARMA CO LTD	489,999	$17	0.0%	$0.16	—	*W EXP 03/15/202	G9845F117
—	MARBLEGATE ACQUISITION CORP	735,000	$14	0.0%	$0.50	—	*W EXP 08/31/202	56608A113
—	HOME PLATE ACQUISITION CORP	690,000	$0	0.0%	$0.60	—	*W EXP 09/30/202	43734R111
—	CHURCHILL CAPITAL CORP V	612,000	$0	0.0%	$1.30	—	*W EXP 10/29/202	17144T115